Next Article in Journal
The Effect of Remimazolam Compared to Sevoflurane on Postoperative Shivering in Patients Undergoing Laparoscopic Gynecologic Surgery under General Anesthesia: A Prospective Randomized Controlled Trial
Next Article in Special Issue
Comorbid Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Current Understanding, Risk Factors, Implications for Clinical Practice, and Suggested Interventions
Previous Article in Journal
Colitis as the Main Presentation of COVID-19: A Case Report
Previous Article in Special Issue
The Relationship of Cholesterol Responses to Mitochondrial Dysfunction and Lung Inflammation in Chronic Obstructive Pulmonary Disease
 
 
Article
Peer-Review Record

Comparison of BODE and ADO Indices in Predicting COPD-Related Medical Costs

Medicina 2023, 59(3), 577; https://doi.org/10.3390/medicina59030577
by Chin-Ling Li 1, Hui-Chuan Chang 1, Ching-Wan Tseng 1, Yuh-Chyn Tsai 1, Jui-Fang Liu 2,3, Meng-Lin Tsai 4, Meng-Chih Lin 1,4,5 and Shih-Feng Liu 1,4,5,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Medicina 2023, 59(3), 577; https://doi.org/10.3390/medicina59030577
Submission received: 27 January 2023 / Revised: 9 March 2023 / Accepted: 13 March 2023 / Published: 15 March 2023
(This article belongs to the Special Issue Update on COPD and Cystic Fibrosis)

Round 1

Reviewer 1 Report

This is a retrospective, correlation study investigating whether the BODE and ADO indices can be used for predicting COPD-related medical expenses in Taiwan. The authors found that both indices produced similar predictions for outpatient medical expenses, however the BODE index slightly outperformed the ADO index in predicting hospitalization expenses amongst others.

The manuscript is adequately detailed with appropriate study design and description of the methods and results. I have few concerns:

1) Please add currency in Table 2 in the costs (e.g. NT$ in the column).

2) In the Discussion section, it would be beneficial to comment on the results, e.g. the highest R2-values are 0.128 for the BODE index and 0.071 for the ADO index. Would it mean that they correlate good with e.g. days of hospitalization or not? Are the BODE and ADO indices great in predicting COPD-related medical expenses? The authors have only commented on whether the BODE and ADO indices produced similar results or when BODE slightly outperformed ADO.

3) The comment above should also be reflected in the Conclusions section (both in main body and abstract).

Thank you for this manuscript!

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 2 Report

This is a retrospective study aimed at investigating BODE and ADO accuracy in predicting medical costs related to COPD.

 

Although the question is relevant, the conclusions of the study are based on data collected retrospectively from a single center. 

The study has several limitations, many points should be addressed and revised.

 

Paragraph 2.1 study design: this paragraph is not enough clear and should be reformulated.

 

Line 93: ICD-9- 93 CM: 490–496 and ICD-10-CM: J41–J44 should be defined.

 

The large majority of the sample is represented by males, with less than 5% of women included. This could represent a confounding factor. The authors explained this is a limitation, anyway the results should not be considered as general, due to this limit. 

 

The authors state in the paragraph 2.2 that 6 min walking tests of the included patients were analyzed, and it appears at the top of the figure 1 relative to the selection of patients. However this point has not been further considered in the manuscript.

 

The conclusions only partly answer the research question.

 

Overall, the manuscript in the present form appears not suitable for publication.

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

The revised version has been adequately improved.

Please correct AOD in ADO through the text.

Author Response

Please see the attachment

Author Response File: Author Response.docx

Back to TopTop